Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · IEX Real-Time Price · USD
2.680
+0.060 (2.29%)
At close: Mar 28, 2024, 4:00 PM
2.710
+0.030 (1.12%)
After-hours: Mar 28, 2024, 7:53 PM EDT

Esperion Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2011
Cash & Equivalents
82.25124.78258.89304.96167.0636.9734.4738.1777.3485.04
Upgrade
Short-Term Investments
042.0950.44034.6599.05165.73173.42134.9320.8
Upgrade
Cash & Cash Equivalents
82.25166.86309.33304.96201.71136.02200.2211.58212.26105.84
Upgrade
Cash Growth
-50.71%-46.06%1.43%51.19%48.29%-32.06%-5.38%-0.32%100.55%76.22%
Upgrade
Receivables
48.4933.7322.9312.39000000
Upgrade
Inventory
65.6235.234.3916.14000000
Upgrade
Other Current Assets
4.710.89-37.6912.4110.016.613.731.992.130.86
Upgrade
Total Current Assets
201.07246.68328.97345.9211.71142.63203.92213.58214.39106.7
Upgrade
Property, Plant & Equipment
4.681.22.567.312.680.520.440.670.810.78
Upgrade
Long-Term Investments
000000.2473.4230.9180.3235.74
Upgrade
Goodwill and Intangibles
0.060.060.060.060.060.060.060.060.060.06
Upgrade
Other Long-Term Assets
00500000000
Upgrade
Total Long-Term Assets
4.731.2652.627.362.730.8273.9131.6481.1836.58
Upgrade
Total Assets
205.8247.94381.59353.26214.45143.45277.84245.21295.57143.28
Upgrade
Accounts Payable
31.7223.0417.5651.9828.8644.8920.384.60.712.04
Upgrade
Deferred Revenue
25.43.516.321.662.1500000
Upgrade
Current Debt
36.3825.1412.697.985.6901.051.711.60.64
Upgrade
Other Current Liabilities
62.7240.6236.7932.4529.3819.4411.729.293.312.81
Upgrade
Total Current Liabilities
156.2292.3173.3594.0766.0864.3333.1415.595.635.49
Upgrade
Long-Term Debt
504.57479.41504.55354.03128.42001.022.694.23
Upgrade
Other Long-Term Liabilities
000.631.29000000
Upgrade
Total Long-Term Liabilities
504.57479.41505.18355.32128.42001.022.694.23
Upgrade
Total Liabilities
660.79571.72578.53449.39194.564.3333.1416.618.319.72
Upgrade
Total Debt
540.95504.55517.24362.01134.1101.052.734.294.87
Upgrade
Debt Growth
7.21%-2.45%42.88%169.94%---61.74%-36.37%-11.85%-
Upgrade
Retained Earnings
-1,549.28-1,340.04-1,106.38-838.82-695.27-598.1-396.29-229.2-154.22-104.44
Upgrade
Comprehensive Income
0-0-0.0300.02-0.32-0.85-0.17-0.48-0.06
Upgrade
Shareholders' Equity
-454.99-323.78-196.94-96.1319.9579.12244.69228.6287.26133.55
Upgrade
Net Cash / Debt
-458.7-337.69-207.9-57.0567.6136.02199.15208.85207.97100.97
Upgrade
Net Cash / Debt Growth
-----50.30%-31.70%-4.64%0.42%105.97%68.11%
Upgrade
Net Cash Per Share
-4.45-5.09-7.19-2.082.505.088.329.269.446.17
Upgrade
Working Capital
44.84154.38255.62251.83145.6378.3170.78197.99208.77101.21
Upgrade
Book Value Per Share
-4.41-4.88-6.81-3.500.742.9610.2210.1413.048.16
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).